FB
Fortress Biotech, Inc.
FBIO · NASDAQ
$2.46 -0.81% (-$0.02)
1M -15.46%
Market Cap $81.7M
P/E Ratio 0.73x
Div. Yield -
ROE 103.52%
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/E 0.73x
P/S 1.19x
P/FCF 0.65x
Growth
13 /100
Declining Rev. growth 5.83%
Book val. growth 6.13%
EPS growth N/A
Profitability
70 /100
Strong Gross margin 62.53%
Net margin 163.32%
FCF margin 183.80%
Quality
48 /100
Average ROIC 10.85%
ROE 103.52%
Asset turnover 0.22x
Debt
98 /100
Low Debt/Equity 0.39x
Current ratio 3.96x
Net debt/EBITDA -0.82x
Stability
53 /100
Moderate Beta 1.19x
Rev. volatility 24.49%
Profitable years 1
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na FBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Lindsay A. Rosenwald
Employees
78
Headquarters
Bay Harbor Islands
Nadcházející události
16 LIS
Earnings
Upcoming earnings report